brl-28500 and Hematologic-Diseases

brl-28500 has been researched along with Hematologic-Diseases* in 1 studies

Other Studies

1 other study(ies) available for brl-28500 and Hematologic-Diseases

Article	Year
[Effect of clavulanic acid/ticarcillin on severe infections accompanying hematological diseases]. The Japanese journal of antibiotics, 1987, Volume: 40, Issue:4 Clavulanic acid/ticarcillin (BRL 28500) was administered to 36 patients with severe infections accompanying various hematological diseases. The rate of efficacy was 52% on the whole. Adverse reactions were minimal. Topics: Adult; Aged; Bacterial Infections; Clavulanic Acids; Drug Combinations; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillins; Ticarcillin	1987

Article

Year

[Effect of clavulanic acid/ticarcillin on severe infections accompanying hematological diseases].

The Japanese journal of antibiotics, 1987, Volume: 40, Issue:4

Clavulanic acid/ticarcillin (BRL 28500) was administered to 36 patients with severe infections accompanying various hematological diseases. The rate of efficacy was 52% on the whole. Adverse reactions were minimal.

Topics: Adult; Aged; Bacterial Infections; Clavulanic Acids; Drug Combinations; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillins; Ticarcillin

1987